Montelukast API Market Size: Exploring Industry Trends & Analyzing Share, and Growth in 2034
The global Montelukast API market was valued at approximately USD 1.6 billion in 2024 and is projected to reach USD 2.7 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period. This growth is attributed to the increasing global demand for Montelukast-based therapies for asthma, allergic rhinitis, and other inflammatory conditions. The increasing prevalence of respiratory diseases, combined with growing awareness and affordable drug formulations, is expected to drive the market over the next decade.
Montelukast API Industry Demand